Identification and Regulation of the IGFBP-4 Protease and Its Physiological Inhibitor in Human Trophoblasts and Endometrial Stroma: Evidence for Paracrine Regulation of IGF-II Bioavailability in the Placental Bed during Human Implantation
L. C. Giudice,
C. A. Conover,
L. Bale,
G. H. Faessen,
K. Ilg,
I. Sun,
B. Imani,
L.-F. Suen,
J. C. Irwin1,
M. Christiansen,
M. T. Overgaard and
C. Oxvig
Department of Gynecology and Obstetrics (L.C.G., G.H.F., K.I., I.S., B.I., L.-F.S., J.C.I.), Stanford University Medical Center, Stanford, California 94305; Endocrine Research Laboratory (C.A.C., L.B.), The Mayo Foundation, Rochester, Minnesota 55905; The Statens Serum Institut (M.C.), DK-2300 Copenhagen, Denmark; and Department of Molecular and Structural Biology (M.T.O., C.O.), University of Aarhus, DK-8000 Aarhus, Denmark
Address all correspondence and requests for reprints to: Linda C. Giudice, Ph.D., M.D., Division of Reproductive Endocrinology and Infertility, Center for Research on Womens Health and Reproductive Medicine, Department of Gynecology and Obstetrics, Stanford University Medical Center, Stanford, California 94305-5317. E-mail: . giudice{at}stanford.edu
Abstract
The IGF family plays an important role in implantation and placentalphysiology. IGF-II is abundantly expressed by placental trophoblasts,and IGF binding protein (IGFBP)-4, a potent inhibitor of IGFactions, is the second most abundant IGFBP in the placentalbed, expressed exclusively by the maternal decidua. Proteolysisof IGFBP-4 results in decreased affinity for IGF peptides, therebyenhancing IGF actions. In the current study, we have identifiedthe IGFBP-4 protease and its inhibitor in human trophoblastand decidualized endometrial stromal cell cultures, and we haveinvestigated their regulation in an effort to understand controlof IGF-II bioavailability at the placental-decidual interfacein human implantation. IGFBP-4 protease activity was detectedin conditioned media (CM) from human trophoblasts and decidualizedendometrial stromal cells using 125I-IGFBP-4 substrate. Identificationof the IGFBP-4 protease as pregnancy-associated plasma protein-A(PAPP-A) was confirmed by specific immunoinhibition and immunodepletionof the IGFBP-4 protease activity with specific PAPP-A antibodies.The IGFBP-4 protease activity was IGF-II-dependent in trophoblastCM. In decidualized stromal CM, PAPP-A/IGFBP-4 protease activitywas also IGF-II-dependent, but was evident only when IGF-IIwas added in molar excess of the predominant IGFBP in decidualizedstromal cell CM, IGFBP-1, supporting bioavailable IGF-II asa key cofactor of IGFBP-4 proteolysis by PAPP-A. Cultured firstand second trimester human trophoblasts (n = 5) secreted PAPP-Ainto CM with mean ± SEM levels of 172.4 ± 32.8mIU/liter·105 cells, determined by specific ELISA. PAPP-Ain trophoblast CM (n = 3) and did not change in the presenceof IGF-II (1100 ng/ml). Cultured human endometrial stromalcells (n = 4) secreted low levels of PAPP-A (6.25 ± 3.6mIU/liter·105 cells). A physiological inhibitor of PAPP-A,the proform of eosinophil major basic protein (proMBP), wasdetected in trophoblast CM at levels of 1853 ± 308 mIU/liter·105cells, determined by specific ELISA, and was nearly undetectablein CM of human endometrial stromal cells. Upon in vitro decidualizationof endometrial stromal cells with progesterone, PAPP-A levelsin CM increased nearly 9-fold without a concomitant change inproMBP. In contrast to the experiments with trophoblasts, IGF-IIand the IGF analogues, Leu27 IGF-II, and Des (16) IGF-II,resulted in a dose-dependent decrease of PAPP-A levels in decidualizedendometrial stromal CM by 7090%, and a dose-dependentincrease in proMBP of 14- to 41-fold. The data demonstrate conclusivelythat the IGF-II-dependent IGFBP-4 protease of human trophoblastand decidual origin is PAPP-A. Furthermore, the differentialregulation of decidual PAPP-A and proMBP by insulin-like peptidessupports a role for trophoblast-derived IGF-II as a paracrineregulator of these maternal decidual products that have thepotential to regulate IGF-II bioavailability at the trophoblast-decidualinterface. Overall, the data underscore potential roles fora complex family of enzyme (PAPP-A), substrate (IGFBP-4), inhibitor(proMBP), and cofactor (IGF-II) in the placental bed duringhuman implantation.
This article has been cited by other articles:
J. Wang, Q. Qiu, M. Haider, M. Bell, A. Gruslin, and J. K Christians Expression of pregnancy-associated plasma protein A2 during pregnancy in human and mouse
J. Endocrinol.,
September 1, 2009;
202(3):
337 - 345.
[Abstract][Full Text][PDF]
D.J. Amor, J.X. Xu, J.L. Halliday, I. Francis, D.L. Healy, S. Breheny, H.W.G. Baker, and A.M. Jaques Pregnancies conceived using assisted reproductive technologies (ART) have low levels of pregnancy-associated plasma protein-A (PAPP-A) leading to a high rate of false-positive results in first trimester screening for Down syndrome
Hum. Reprod.,
June 1, 2009;
24(6):
1330 - 1338.
[Abstract][Full Text][PDF]
C. Ganeff, G. Chatel, C. Munaut, F. Frankenne, J.-M. Foidart, and R. Winkler The IGF system in in-vitro human decidualization
Mol. Hum. Reprod.,
January 1, 2009;
15(1):
27 - 38.
[Abstract][Full Text][PDF]
D. P. Jones Radical-free biology of oxidative stress
Am J Physiol Cell Physiol,
October 1, 2008;
295(4):
C849 - C868.
[Abstract][Full Text][PDF]
J. H. Mikkelsen, C. Gyrup, P. Kristensen, M. T. Overgaard, C. B. Poulsen, L. S. Laursen, and C. Oxvig Inhibition of the Proteolytic Activity of Pregnancy-associated Plasma Protein-A by Targeting Substrate Exosite Binding
J. Biol. Chem.,
June 13, 2008;
283(24):
16772 - 16780.
[Abstract][Full Text][PDF]
A. M. Carter Maintaining the integrity of trophoblast during growth of the placenta. Focus on "Insulin-like growth factor I and II regulate the life cycle of trophoblast in the developing human placenta"
Am J Physiol Cell Physiol,
June 1, 2008;
294(6):
C1303 - C1304.
[Full Text][PDF]
Y. Ning, A. G. P. Schuller, C. A. Conover, and J. E. Pintar Insulin-Like Growth Factor (IGF) Binding Protein-4 Is Both a Positive and Negative Regulator of IGF Activity in Vivo
Mol. Endocrinol.,
May 1, 2008;
22(5):
1213 - 1225.
[Abstract][Full Text][PDF]
K. Weyer, H. B. Boldt, C. B. Poulsen, K. Kjaer-Sorensen, C. Gyrup, and C. Oxvig A Substrate Specificity-determining Unit of Three Lin12-Notch Repeat Modules Is Formed in Trans within the Pappalysin-1 Dimer and Requires a Sequence Stretch C-terminal to the Third Module
J. Biol. Chem.,
April 13, 2007;
282(15):
10988 - 10999.
[Abstract][Full Text][PDF]
S. Glerup, S. Kloverpris, L. S. Laursen, F. Dagnaes-Hansen, S. Thiel, C. A. Conover, and C. Oxvig Cell Surface Detachment of Pregnancy-associated Plasma Protein-A Requires the Formation of Intermolecular Proteinase-Inhibitor Disulfide Bonds and Glycosaminoglycan Covalently Bound to the Inhibitor
J. Biol. Chem.,
January 19, 2007;
282(3):
1769 - 1778.
[Abstract][Full Text][PDF]
V. E. Murphy, R. Smith, W. B. Giles, and V. L. Clifton Endocrine Regulation of Human Fetal Growth: The Role of the Mother, Placenta, and Fetus
Endocr. Rev.,
April 1, 2006;
27(2):
141 - 169.
[Abstract][Full Text][PDF]
S. Glerup, H. B. Boldt, M. T. Overgaard, L. Sottrup-Jensen, L. C. Giudice, and C. Oxvig Proteinase Inhibition by Proform of Eosinophil Major Basic Protein (pro-MBP) Is a Multistep Process of Intra- and Intermolecular Disulfide Rearrangements
J. Biol. Chem.,
March 18, 2005;
280(11):
9823 - 9832.
[Abstract][Full Text][PDF]
K. Hayashi, K. D Carpenter, T. H Welsh Jr, R. C Burghardt, L. J Spicer, and T. E Spencer The IGF system in the neonatal ovine uterus
Reproduction,
March 1, 2005;
129(3):
337 - 347.
[Abstract][Full Text][PDF]
S. C.J.P. Gielen, E. E. Hanekamp, L. J. Blok, F. J. Huikeshoven, and C. W. Burger Steroid-Modulated Proliferation of Human Endometrial Carcinoma Cell Lines: Any Role for Insulin-like Growth Factor Signaling?
Reproductive Sciences,
January 1, 2005;
12(1):
58 - 64.
[Abstract][PDF]
Q.-P. Qin, S. Kokkala, J. Lund, N. Tamm, L.-M. Voipio-Pulkki, and K. Pettersson Molecular Distinction of Circulating Pregnancy-Associated Plasma Protein A in Myocardial Infarction and Pregnancy
Clin. Chem.,
January 1, 2005;
51(1):
75 - 83.
[Abstract][Full Text][PDF]
H. B. Boldt, K. Kjaer-Sorensen, M. T. Overgaard, K. Weyer, C. B. Poulsen, L. Sottrup-Jensen, C. A. Conover, L. C. Giudice, and C. Oxvig The Lin12-Notch Repeats of Pregnancy-associated Plasma Protein-A Bind Calcium and Determine Its Proteolytic Specificity
J. Biol. Chem.,
September 10, 2004;
279(37):
38525 - 38531.
[Abstract][Full Text][PDF]
A. De Luca, M. De Falco, V. Fedele, L. Cobellis, A. Mastrogiacomo, V. Laforgia, I. L. Tuduce, M. Campioni, D. Giraldi, M. G. Paggi, et al. The Serine Protease HtrA1 Is Upregulated in the Human Placenta During Pregnancy
J. Histochem. Cytochem.,
July 1, 2004;
52(7):
885 - 892.
[Abstract][Full Text][PDF]
F. W. Anthony, D. D. Mukhtar, M. A. Pickett, and I. T. Cameron Progesterone Up-Regulates WT1 mRna and Protein, and Alters the Relsative Expression of WT1 Transcripts in Cultured Endometrial Stromal Cells
Reproductive Sciences,
December 1, 2003;
10(8):
509 - 516.
[Abstract][PDF]
M. T. Overgaard, E. S. Sorensen, D. Stachowiak, H. B. Boldt, L. Kristensen, L. Sottrup-Jensen, and C. Oxvig Complex of Pregnancy-associated Plasma Protein-A and the Proform of Eosinophil Major Basic Protein. DISULFIDE STRUCTURE AND CARBOHYDRATE ATTACHMENT SITES
J. Biol. Chem.,
January 17, 2003;
278(4):
2106 - 2117.
[Abstract][Full Text][PDF]
L. S. Laursen, M. T. Overgaard, K. Weyer, H. B. Boldt, P. Ebbesen, M. Christiansen, L. Sottrup-Jensen, L. C. Giudice, and C. Oxvig Cell Surface Targeting of Pregnancy-associated Plasma Protein A Proteolytic Activity. REVERSIBLE ADHESION IS MEDIATED BY TWO NEIGHBORING SHORT CONSENSUS REPEATS
J. Biol. Chem.,
November 27, 2002;
277(49):
47225 - 47234.
[Abstract][Full Text][PDF]
I. Y. C. Sun, M. T. Overgaard, C. Oxvig, and L. C. Giudice Pregnancy-Associated Plasma Protein A Proteolytic Activity Is Associated with the Human Placental Trophoblast Cell Membrane
J. Clin. Endocrinol. Metab.,
November 1, 2002;
87(11):
5235 - 5240.
[Abstract][Full Text][PDF]